|
Upon its establishment in 1992, Medinol revolutionized the field of interventional cardiology with the invention of the flexible closed cell stent design. As a pioneer in the field of stenting solutions, Medinol has continuously advanced stenting technology by creating increasingly effective products.
Our products excel in combining the flexibility needed to facilitate quick & easy deployment, with conformability to the vessel shape and the stability needed to maintain long-lasting scaffolding & clinical outcome.
Medinol’s unique core technology, robust production capabilities,
unparalleled quality control and breakthrough designs are the aggregated
result of our team’s multidisciplinary expertise.
With the introduction of a new line of stenting solutions and strategic partnerships with leading global companies, Medinol maintains its unique position as an innovation leader.
|
|
